Valuation Burning Rock Biotech Limited
Stocks
BNR
US12233L2060
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.040 USD | -13.41% |
|
-15.49% | -65.06% |
| 06-09 | Burning Rock Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-13 | Aurelion Inc. Announces Executive Changes, Effective April 13, 2026 | CI |
Company Valuation: Burning Rock Biotech Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 15,655 | 6,329 | 1,632 | 695.3 | 505.4 | 1,517 |
| Change | - | -59.57% | -74.21% | -57.4% | -27.31% | 200.22% |
| Enterprise Value (EV) 1 | 13,439 | 4,919 | 775.6 | 79.16 | 31.77 | 1,080 |
| Change | - | -63.4% | -84.23% | -89.79% | -59.86% | 3,298.37% |
| P/E | -21.9x | -7.92x | -1.66x | -1.03x | -1.46x | -27.1x |
| PBR | 6.53x | 3.45x | 1.38x | 0.88x | 0.91x | 2.77x |
| PEG | - | -0.7x | -0.1x | 0x | 0x | 0.3x |
| Capitalization / Revenue | 36.4x | 12.5x | 2.9x | 1.29x | 0.98x | 2.81x |
| EV / Revenue | 31.3x | 9.69x | 1.38x | 0.15x | 0.06x | 2x |
| EV / EBITDA | -35.4x | -6.54x | -0.9x | -0.15x | -0.12x | -32.5x |
| EV / EBIT | -32.6x | -6.17x | -0.79x | -0.12x | -0.1x | -19.7x |
| EV / FCF | -621x | -16.1x | -3.52x | -1.38x | -4.12x | -47.4x |
| FCF Yield | -0.16% | -6.21% | -28.4% | -72.6% | -24.3% | -2.11% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -68.76 | -76.45 | -93.47 | -63.84 | -33.67 | -5.206 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 429.9 | 507.9 | 563.2 | 537.4 | 515.8 | 539.6 |
| EBITDA 1 | -379.9 | -752.5 | -859.7 | -537.9 | -271 | -33.22 |
| EBIT 1 | -412.4 | -797.1 | -980.4 | -669.3 | -322.4 | -54.84 |
| Net income 1 | -407.2 | -796.7 | -971.2 | -653.7 | -346.6 | -55.35 |
| Net Debt 1 | -2,216 | -1,410 | -856.8 | -616.2 | -473.7 | -437.7 |
| Reference price 2 | 1,508.11 | 605.40 | 155.19 | 65.95 | 49.27 | 140.94 |
| Nbr of stocks (in thousands) | 10,380 | 10,455 | 10,519 | 10,544 | 10,259 | 10,767 |
| Announcement Date | 3/23/21 | 4/29/22 | 4/20/23 | 4/29/24 | 4/29/25 | 4/28/26 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 85.74M | |
| 19.24x | 0.88x | 10.36x | -.--% | 9.25B | |
| 12.37x | 0.22x | 4.74x | 2.86% | 1.22B | |
| 16.84x | 1.2x | 9.13x | 2.91% | 951M | |
| -3.35x | 0.68x | 5.15x | 0.08% | 235M | |
| Average | 11.28x | 0.75x | 7.34x | 1.46% | 2.35B | |
| Weighted average by Cap. | 17.87x | 0.83x | 9.56x | 0.54% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BNR Stock
- Valuation Burning Rock Biotech Limited
Select your edition
All financial news and data tailored to specific country editions
